Prevalence of primary immune thrombocytopenia in Oklahoma

被引:69
|
作者
Terrell, Deirdra R. [1 ]
Beebe, Laura A. [1 ]
Neas, Barbara R. [1 ]
Vesely, Sara K. [1 ]
Segal, Jodi B. [2 ]
George, James N. [1 ,3 ]
机构
[1] Univ Oklahoma, Hlth Sci Ctr, Coll Publ Hlth, Dept Biostat & Epidemiol, Oklahoma City, OK 73126 USA
[2] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[3] Univ Oklahoma, Hlth Sci Ctr, Coll Med, Dept Med, Oklahoma City, OK 73126 USA
关键词
QUALITY-OF-LIFE; PURPURA; ADULTS; CHILDHOOD; CHILDREN; PATIENT;
D O I
10.1002/ajh.23262
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To determine the prevalence of immune thrombocytopenia (ITP) in Oklahoma regardless of age, clinical characteristics, insurance status, and source of health care. Patients with ITP were identified by the administrative code ICD-9-CM 287.3 in Oklahoma hematologists' offices for a 2-year period, 20032004. Prevalence was estimated separately for children (<16 years old) and adults because of their distinct clinical characteristics. Oklahoma census data for 2000 was used as the denominator. Eighty-seven (94%) of 93 eligible Oklahoma hematologists participated; 620 patients with ITP were identified. The average annual prevalences were as follows: 8.1 (95% CI: 6.79.5) per 100,000 children, 12.1 (95% CI: 11.113.0) per 100,000 adults, and 11.2 (95% CI: 10.412.0) per 100,000 population. Among children and adults less than age 70 years, the prevalence was greater among women. Among adults aged 70 years and older, the prevalence was greater among men. The highest prevalence of ITP was among men age 80 years and older. These data document for the first time the prevalence of ITP regardless of age, clinical characteristics, insurance status, and source of health care. The methodology developed for this prevalence analysis may be adaptable for epidemiologic studies of other uncommon disorders which lack specific diagnostic criteria and are treated primarily by medical specialists. Am. J. Hematol. 2012. (c) 2012 Wiley Periodicals, Inc.
引用
收藏
页码:848 / 852
页数:5
相关论文
共 50 条
  • [41] PROGNOSIS VARIABLES IN INFANT PRIMARY IMMUNE THROMBOCYTOPENIA
    Gonzalez, de Pablo Jesus
    Gonzalez-Vicent, Marta
    Andres, Esteban Eva Maria
    Galvez, Eva
    Zubicaray, Josune
    Castillo, Ana
    Perez, Maroto Florencio
    Madero, Luis
    Sevilla, Julian
    Sebastian, Elena
    HAEMATOLOGICA, 2020, 105 : 284 - 284
  • [42] Risk and prognosis of adult primary immune thrombocytopenia
    Frederiksen, Henrik
    Christiansen, Christian Fynbo
    Norgaard, Mette
    EXPERT REVIEW OF HEMATOLOGY, 2012, 5 (02) : 219 - 228
  • [43] Fibrinolysis is impaired in patients with primary immune thrombocytopenia
    Schramm, Theresa
    Rast, Jasmin
    Mehic, Dino
    Reitsma, Stephanie E.
    de Moreuil, Claire
    Fillitz, Michael
    Quehenberger, Peter
    de Laat, Bas
    Wolberg, Alisa S.
    Ay, Cihan
    Pabinger, Ingrid
    Gebhart, Johanna
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2024, 22 (11) : 3209 - 3220
  • [44] Efgartigimod alfa for the treatment of primary immune thrombocytopenia
    Broome, Catherine
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2023, 14
  • [45] PROGNOSTIC FACTORS IN PRIMARY IMMUNE THROMBOCYTOPENIA OF CHILDHOOD
    Gkoutsias, A.
    Palianopoulos, T.
    Pappa, E.
    Papapetrou, E.
    Tsaousi, C.
    Chaliasos, N.
    Makis, A.
    HAEMATOLOGICA, 2017, 102 : 833 - 833
  • [46] Diagnosis and management of primary immune thrombocytopenia in adults
    Ejaz, Ayesha
    Radia, Deepti
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2019, 80 (04) : C53 - C56
  • [47] Pathophysiology and therapeutic options in primary immune thrombocytopenia
    Stasi, Roberto
    BLOOD TRANSFUSION, 2011, 9 (03) : 262 - 273
  • [48] Primary Immune-Mediated Thrombocytopenia in Cats
    Wondratschek, Christina
    Weingart, Christiane
    Kohn, Barbara
    JOURNAL OF THE AMERICAN ANIMAL HOSPITAL ASSOCIATION, 2010, 46 (01) : 12 - 19
  • [49] The Influence of Malnutrition on Outcomes in Primary Immune Thrombocytopenia
    Akhiwu, Ted
    Bohara, Gagan
    Singh, Tanmay
    Kanemo, Philip
    Mohebtash, Mahsa
    Gangireddy, Mounika
    BLOOD, 2024, 144 : 5432 - 5433
  • [50] Immune Thrombocytopenia in Antiphospholipid Syndrome: Is It Primary or Secondary?
    Tomasello, Riccardo
    Giordano, Giulio
    Romano, Francesco
    Vaccarino, Federica
    Siragusa, Sergio
    Lucchesi, Alessandro
    Napolitano, Mariasanta
    BIOMEDICINES, 2021, 9 (09)